Access 20 Verified Employees Profiles for Swanbio TherapeuticsUnlock Free Contacts Now
About
SwanBio is now part of Spur Therapeutics. Our potential first-in-class gene therapy candidate for adrenomyeloneuropathy (AMN) has joined Spur’s expanding pipeline of next-generation genetic medicines. Learn more at spurtherapeutics.com.